Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activationAbdullah Al‐Dhfyan, Hesham M. Korashy|Molecular Cancer|2017Cited by 216
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinomaSarita Saraswati, Hesham M. Korashy|Cell Communication and Signaling|2019Cited by 56
Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition PathwaysLubna Therachiyil, Hesham M. Korashy|International Journal of Molecular Sciences|2022Cited by 37
Gold-containing compound BDG-I inhibits the growth of A549 lung cancer cells through the deregulation of miRNA expressionAli Alhoshani, Hesham M. Korashy, Anvarhusein A. Isab et al.|Saudi Pharmaceutical Journal|2018Cited by 8
Therapeutic potential of carfilzomib, an irreversible proteasome inhibitor, against acetaminophen-induced hepatotoxicity in miceAbdulrazaq Alanazi, Mahmoud N. Nagi, Saleh G. Algfeley et al.|Journal of Biochemical and Molecular Toxicology|2016Cited by 7